Atherosclerosis is the major process underlying cardiovascular disorders, and accounts for the majority of mortality and morbidity in the western world. This course will give more insights into the mechanism and ontogenesis of vessel narrowing (atherosclerosis). Special emphasis will be put on the contribution of inflammatory processes and lipid fluxes in the development of atherosclerotic lesions. Also the clinical end-points of atherosclerosis will be discussed.
The following subjects will be discussed:
Cholesterol metabolism and atherosclerotic lesion formation
Role of macrophages in atherosclerotic lesion formation
Role of inflammation in atherosclerotic lesion formation and progression
Therapeutic approaches for the stabilization of vulnerable atherosclerotic plaques
Prof. dr. Johan Kuiper
Students of Bio-Pharmaceutical Sciences.
Will be announced during the lectures.
Minimum of 5 students
The lecture series Biopharmaceutics (Atherosclerosis) will be given in 2013—2014 from November 25—29. The examination is on December 12th 2013.
For information, please contact Prof. dr. Johan Kuiper (e-mail: email@example.com, tel. 527 4378).
Application via uSis.